Treatment Category Profile

Treatment Name:	Bevacizumab	Known as: Also Known As:	Bevacizumab Avastin
Treatment Type:	Multi-Targeted	Status:	FDA Approved (phase II)

   Articles related to this Treatment

1 FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma DocGuide Jan 8, 2010 2 Bevacizumab safety in patients with central nervous system metastases DocGuide Jan 1, 2010 3 FDA Approves Avastin for Most Common Kidney Cancer HER News Aug 4, 2009 4 Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma Journal of Clinical Oncology Jul 27, 2009 5 Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Therapy Journal of Clinical Oncology Jan 10, 2009 6 New Drug Delays Kidney Cancer Progression reuters.com Jul 31, 2003 7 Bevacizumab May Be Helpful in Metastatic Renal-Cell Carcinoma Medscape Jul 30, 2003 8 Drug may help treat kidney cancer msnbc Jul 30, 2003 9 Avastin as monotherapy Oncology Week in Review May 23, 2002 10 Angiogenesis Inhibitor Appears to Delay Kidney Cancer Progression cancerpage.com May 22, 2002 11 Drug May Delay Kidney Cancer Progression Reuters Health May 20, 2002 12 NCI -- Study Demonstrates Genentech's Investigational Anti-Angiogenesis Treatment Avastin Delays Time to Disease Progression in Metastatic Kidney Cancer Yahoo! Finance May 20, 2002 13 Molecularly Targeted Drug Slows Tumor Growth in Patients With Metastatic Kidney Cancer NIH News May 19, 2002 14 Drug That Blocks Blood Flow Slows Tumor Growth in Trial NY Times May 19, 2002 15 Drug Slows Kidney Cancer Tumor Growth HealthScoutNews May 16, 2002